Apex Innovative Sciences

Apex Innovative Sciences is a health care startup that is making waves in the industry with its focus on high-quality clinical trials for central nervous system conditions and a wide range of therapeutic fields. Founded in 2019, the company is committed to upholding the highest standards of scientific and clinical quality for both its client partners and trial participants. The slogan "Leading the way in high-quality clinical trials for central nervous system conditions and a wide range of therapeutic fields" encapsulates the company's mission and vision. Apex Innovative Sciences operates as an independent clinical trial site with a specific emphasis on studies related to central nervous system conditions, neurology, psychiatry, and addiction, offering a unique value proposition within the health care industry. In October 2019, the company received a Private Equity Round investment from Bison Capital, signifying a vote of confidence in the startup's potential and growth prospects. This investment is a testament to the recognition of Apex's innovative approach and the market demand for its specialized services. With its impressive focus and achievements in the health care sector, Apex Innovative Sciences is poised to play a significant role in shaping the future of clinical trials and treatment approaches for central nervous system conditions and other therapeutic areas. This, combined with the backing of Bison Capital, positions the company for continued success and expansion within the industry.